Committed to developing
novel vaccines
We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.
Join a dynamic team dedicated to making a difference
Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture.
Recent News
Dynavax Files Preliminary Proxy Statement
Apr 03, 2025
DYNAVAX®, HEPLISAV-B®, and CpG 1018® are registered trademarks of Dynavax Technologies Corporation.